As of 2025-10-28, the Relative Valuation of Amneal Pharmaceuticals Inc (AMRX) is 0.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.25 USD, the upside of Amneal Pharmaceuticals Inc based on Relative Valuation is -96.6%.
The range of the Relative Valuation is 0.30 - 0.45 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.6x - 41.5x | 32.5x |
| Forward P/E multiples | 27.5x - 37.4x | 32.8x |
| Fair Price | 0.30 - 0.45 | 0.35 |
| Upside | -97.1% - -95.6% | -96.6% |
| Date | P/E |
| 2025-10-16 | 918.51 |
| 2025-10-15 | 910.13 |
| 2025-10-14 | 904.55 |
| 2025-10-13 | 907.34 |
| 2025-10-10 | 927.82 |
| 2025-10-09 | 957.60 |
| 2025-10-08 | 975.28 |
| 2025-10-07 | 964.11 |
| 2025-10-06 | 981.79 |
| 2025-10-03 | 966.90 |
| 2025-10-02 | 967.83 |
| 2025-10-01 | 965.97 |
| 2025-09-30 | 931.54 |
| 2025-09-29 | 918.51 |
| 2025-09-26 | 907.34 |
| 2025-09-25 | 893.38 |
| 2025-09-24 | 903.62 |
| 2025-09-23 | 915.72 |
| 2025-09-22 | 930.61 |
| 2025-09-19 | 912.93 |
| 2025-09-18 | 912.93 |
| 2025-09-17 | 894.31 |
| 2025-09-16 | 906.41 |
| 2025-09-15 | 911.06 |
| 2025-09-12 | 930.61 |
| 2025-09-11 | 938.98 |
| 2025-09-10 | 913.86 |
| 2025-09-09 | 920.37 |
| 2025-09-08 | 905.48 |
| 2025-09-05 | 895.24 |
| 2025-09-04 | 888.73 |
| 2025-09-03 | 887.80 |
| 2025-09-02 | 891.52 |
| 2025-08-29 | 889.66 |
| 2025-08-28 | 888.73 |
| 2025-08-27 | 871.05 |
| 2025-08-26 | 872.91 |
| 2025-08-25 | 863.60 |
| 2025-08-22 | 892.45 |
| 2025-08-21 | 886.87 |
| 2025-08-20 | 875.70 |
| 2025-08-19 | 868.26 |
| 2025-08-18 | 861.74 |
| 2025-08-15 | 879.42 |
| 2025-08-14 | 873.84 |
| 2025-08-13 | 874.77 |
| 2025-08-12 | 839.41 |
| 2025-08-11 | 822.66 |
| 2025-08-08 | 794.74 |
| 2025-08-07 | 764.03 |